DUBLIN--(BUSINESS WIRE)--Dec 1, 2022--
The "Global Direct-To-Consumer Genetic Testing Market 2022-2026" report has been added to ResearchAndMarkets.com's offering.
The direct-to-consumer genetic testing market is poised to grow by $1.26 bn during 2022-2026, accelerating at a CAGR of 13.36% during the forecast period. This report on the direct-to-consumer genetic testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
This report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing adoption of direct-to-consumer genetic testing in early disease diagnosis, rising disposable income, and increasing regulatory approvals of direct-to-consumer genetic testing kits.
The direct-to-consumer genetic testing market analysis includes service segments and geographic landscapes.
The publisher's direct-to-consumer genetic testing market is segmented as below:
By Service
- Diagnostic screening
- Prenatal, newborn screening, and pre-implantation diagnosis
- Relationship testing
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the advances in next-generation genetic sequencing as one of the prime reasons driving the direct-to-consumer genetic testing market growth during the next few years. Also, a reduction in the cost of services and the growing adoption of online service platforms will lead to sizable demand in the market.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. This report on the direct-to-consumer genetic testing market covers the following areas:
- Direct-to-consumer genetic testing market sizing
- Direct-to-consumer genetic testing market forecast
- Direct-to-consumer genetic testing market industry analysis
Key Topics Covered:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Service
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
Companies Mentioned
- 23andMe Holding Co.
- 24GENETICS S.L.
- Alpha Biolaboratories Ltd.
- Ancestry
- Centrillion Technology Inc.
- Color Genomics Inc.
- Dante Labs Inc.
- DNA Diagnostic Center Inc.
- Full Genomes Corp.
- Helix OpCo LLC
- IntelliGenetics
- Invitae Corp.
- Konica Minolta Inc
- Laboratory Corp. of America Holdings
- MyHeritage Ltd.
- Myriad Genetics Inc.
- Positive Biosciences Ltd.
- Quest Diagnostics Inc.
- Sonora Quest Laboratories
- Victorian Clinical Genetics Services
- Xcode Life Sciences Pvt. Ltd
For more information about this report visit https://www.researchandmarkets.com/r/ecisyz
View source version on businesswire.com:https://www.businesswire.com/news/home/20221201005532/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD: